Hendrickson, Andrea E Wahner <br/><br/>
A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma.  [electronic resource] 

 -  Gynecologic oncology  Feb 2012 
 - 210-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1095-6859 
<br/><br/><label>Standard No.: </label>10.1016/j.ygyno.2011.10.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Benzoquinones--administration & dosage<br/>Biomarkers, Tumor--metabolism<br/>Carcinoma, Ovarian Epithelial<br/>Cell Line, Tumor<br/>Cohort Studies<br/>Deoxycytidine--administration & dosage<br/>Female<br/>HSP70 Heat-Shock Proteins--metabolism<br/>HSP90 Heat-Shock Proteins--metabolism<br/>Humans<br/>Lactams, Macrocyclic--administration & dosage<br/>Middle Aged<br/>Neoplasms, Glandular and Epithelial--drug therapy<br/>Ovarian Neoplasms--drug therapy<br/>Peritoneal Neoplasms--drug therapy<br/>Survival Rate<br/>Gemcitabine